Long term health effects of low dose exposure to nerve agent

Journal of Physiology Paris

Volumn 92, Issue 3-4, 1998, Pages 325-328

  Moore, David H ^a  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CYCLOSARIN; NERVE GAS; ORGANOPHOSPHORUS COMPOUND; SARIN; SOMAN; TABUN; UNCLASSIFIED DRUG;

ELECTROENCEPHALOGRAM; EXPOSURE; HEALTH; HUMAN; NEUROTOXICITY; NONHUMAN; REVIEW; VAPOR;

EID: 0032105343     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80041-7     Document Type: Article

References (16)

1. [1] Sidell F.R., Nerve Agents, in: Sidell F.R., Takafuji E.T., Franz D.R. (Eds.), Textbook of Military Medicine, Medical Aspects of Chemical and Biological Warfare, Office of the Surgeon General, US Army, 1997, p. 131.
2. [2] Somani S.M., (Ed.), Chemical Warfare Agents, San Diego, Academic Press, 1992, pp. 156-194.
3. [3] Medical Management of Chemical Casualties Handbook, Chemical Casualty Care Office, Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, 1995, p. 17.
4. [4] Panel on Anticholinesterase Chemicals, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents, Vol. I, Anticholinesterases and Anticholinergics, Committee on Toxicology and Environmental Health Hazards, Assembly of Life Sciences, Washington: National Academy Press, 1982.
5. [5] Coordinating Subcommittee, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents, Vol III, Final Report, Current Health Status of Test Subjects, Committee on Toxicology, Board on Toxicology and Environmental Health Hazards, Commission on Life Sciences, National Research Council, Washington National Academy Press, 1985.
6. [6] Metcalf D.R., Holmes J.W., EEG, Psychological and neurological alterations in humans with organophosphorus exposure, Ann. N.Y. Acad. Sci. 160 (1969) 357-365.
7. [7] Duffy F.H., Burchfiel J.L., Bartels P.H., Gaon M., Sim V.M., Long-term effects of an organophosphate upon the human electroencephalogram, Toxicol. Appl. Pharmacol. 47 (1979) 161-176.
8. [8] Korsak R.J., Sato M.N., Effect of chronic organophosphate exposure on the central nervous system, Clin. Toxicol. 11 (1977) 83-85.
9. [9] Burchfiel J.L., Duffy F.H., Sim V.M., Persistent effects of sarin and dieldrin upon the primate electroencephalogram, Toxicol. Appl. Pharmacol. 35 (1976) 365-379.
10. [10] Shih T.A. et al., Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents, J. Appl. Toxicol. 14 (1994) 195-199.
11. [11] Moore D.H., Low Dose Exposure and Long Term Health Effects of Nerve Agent at CBMTS Middle East I Symposium, December 7-11, Cairo, Egypt, 1997.
12. [12] Kant G.J. et al., Effects of soman on neuroendocrine and immune function, Neurotoxicol. Teratol. 13 (1991) 223-228.
13. [13] Goldman M. et al., Toxicity Studies on Agents GB and GD, University of California, Davis Laboratory for Energy-Related Health Research Final Report, AD-A187841, 1987.
14. [14] LaBorde J.B. et al., Developmental Toxicity Study of Agent GB DCSM Types I and II in NZW Rabbits and CD Rats, Jefferson, AR, National Center for Toxicological Research Final Report, AD-A168331, 1986.
15. [15] Bucci T.J. et al., Toxicity Studies on Agents GB and GD (Phase II): Delayed Neuropathy Study of Sarin, Type II, in SPF White Leghorn Chickens, Jefferson, AR. National Center for Toxicological Research Final Report, AD-A257183, 1992.
16. [16] Sidell F.R. Hurst G.G., The Long-Term Health Effects of Nerve Agents and Mustard, in: Sidell F.R., Takafuji E.T., Franz D.R. (Eds.), Textbook of Military Medicine, Medical Aspects of Chemical and Biological Warfare, Office of the Surgeon General, US Army, 1997, pp. 232.